Extract from the Register of European Patents

EP Citations: EP3972999

Cited inInternational search
Type:Patent literature
Publication No.:WO2016055592  [XI]
 (ENGMAB AG [CH]) [X] 1,2,16,17,19-26,28,29,31-45 * page 9, lines 9-15; figure 1; examples 4-10 * [I] 3-15,18,27,30;
Type:Patent literature
Publication No.:WO2017127499  [XI]
 (JANSSEN BIOTECH INC [US]) [X] 1,2,16,17,19-26,28,29,31-45 * figures 6,8,13; tables 13-18 * [I] 3-15,18,27,30;
Type:Patent literature
Publication No.:US2017233472  [AD]
 (BARAT BHASWATI [US], et al) [AD] 1-45 * paragraph [0244]; figures 12,23-28 *;
Type:Patent literature
Publication No.:WO2019084060  [A]
 (SILVERBACK THERAPEUTICS INC [US]) [A] 1-45 * sequences 362,367 *;
Type:Non-patent literature
Publication information:[XI]  - JUNPENG QI ET AL, "Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20180529), vol. 115, no. 24, doi:10.1073/pnas.1719905115, ISSN 0027-8424, pages E5467 - E5476, XP055715663 [X] 1,2,16,17,19-26,28,29,31-45 * figures 1-8 * [I] 3-15,18,27,30
DOI: http://dx.doi.org/10.1073/pnas.1719905115
Type:Non-patent literature
Publication information:[A]  - SATYEN HARISH GOHIL ET AL, "An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors", ONCOIMMUNOLOGY, (20170517), doi:10.1080/2162402X.2017.1326437, page e1326437, XP055500395 [A] 1-45 * figure 1B *
DOI: http://dx.doi.org/10.1080/2162402X.2017.1326437
Cited inby applicant
Type:Patent literature
Publication No.:US2017233472  
Type:Patent literature
Publication No.:US9856327  
Type:Patent literature
Publication No.:US2018369406  
Type:Non-patent literature
Publication information:   - AL-LAZIKANI et al., JMB, (19970000), vol. 273, pages 927 - 948
Type:Non-patent literature
Publication information:   - MACCALLUM et al., J. Mol. Biol., (19960000), vol. 262, pages 732 - 745
Type:Non-patent literature
Publication information:   - LEFRANC et al., Dev Comp Immunol., (20030000), vol. 27, no. 1, pages 55 - 77
Type:Non-patent literature
Publication information:   - HONEGGERPLUCKTHUN, J Mol Biol, (20010000), vol. 309, no. 3, pages 657 - 70
Type:Non-patent literature
Publication information:   - HONEGGERPLUCKTHUN, JMol Biol, (20010000), vol. 309, no. 3, pages 657 - 70
Type:Non-patent literature
Publication information:   - TUNNACLIFFE et al., International Immunology, (19890000), vol. 1, pages 546 - 550
Type:Non-patent literature
Publication information:   - WANG et al., Cell, (20180000), vol. 9, no. 1, pages 63 - 73
Type:Non-patent literature
Publication information:   - BRINKMANNKONTERMANN, MABS, (20170000), vol. 9, pages 182 - 212
Type:Non-patent literature
Publication information:   - ZHANG et al., Am J Pathol., (20120000), vol. 181, no. 6, pages 1903 - 10
Type:Non-patent literature
Publication information:   - DANESHMANESH et al., LeukLymphoma, (20130000), vol. 54, no. 4, pages 843 - 50
Type:Non-patent literature
Publication information:   - DAVE et al., PLoS One, (20120000), vol. 7, page e52655
Type:Non-patent literature
Publication information:   - CHOI et al., Cell Stem Cell, (20180000), vol. 22, pages 951 - 959
Type:Patent literature
Publication No.:WO2013US32572